Neuropeptide S (NPS) and its receptor were recently discovered in the central nervous system. In rodents, NPS promotes hyperlocomotion, wakefulness, anxiolysis, anorexia, and analgesia and enhances memory when injected intracerebroventricularly (i.c.v.). Herein, NPS at different doses (0.01, 0.1 and 1 nmol) was i.c.v. administered in mice challenged with pentylenetetrazole (PTZ; 60 mg/kg) repeatedly injected. Aiming to assess behavioral alterations and oxidative damage to macromolecules in the brain, NPS was injected 5 min prior to the last dose of PTZ. The administration of NPS only at 1 nmol increased the duration of seizures evoked by PTZ, without modifying frequency and latency of seizures. Biochemical analysis revealed that NPS attenuated PTZ-induced oxidative damage to proteins and lipids in the hippocampus and cerebral cortex. In contrast, the administration of NPS to PTZ-treated mice increased DNA damage in the hippocampus, but not cerebral cortex. In conclusion, this is the first evidence of the potential proconvulsive effects of NPS in mice. The protective effects of NPS against lipid and protein oxidative damage in the mouse hippocampus and cerebral cortex evoked by PTZ-induced seizures are quite unexpected. The present findings were discussed analyzing the paradoxical effects of NPS: facilitation of convulsive behavior and protection against oxidative damage to lipids and proteins.
Introduction
Epilepsy is a chronic disorder characterized by recurrent seizures. This is one of the most common neurological disorders with wide occurrence; the cumulative lifetime risks for epilepsy and for any unprovoked seizure are 3.1% and 4.1%, respectively in industrialized countries (McHugh and Delanty, 2008) . The pathophysiology of epilepsy is largely studied, and a growing body of evidence is suggesting that prolonged seizures may result in mitochondrial dysfunction and increased production of reactive oxygen species. These alterations strongly affect neuronal excitability and synaptic neurotransmission, which contributes to the generation of seizures (for a review see: Folbergrová and Kunz, 2012; Patel, 2004) . Additionally, neurons are much more susceptible than other cells to free radical damage due to the large lipid content of myelin sheaths and the high rate of brain oxidative metabolism (Choi, 1993) . One of the proposed mechanisms by which free radical generation can induce seizure activity is its ability to inactivate the enzyme glutamine synthetase, thus abnormally affecting the metabolism of the excitatory neurotransmitter glutamate (Sudha et al., 2001 ).
The administration of pentylenetetrazole (PTZ), which is a GABA A receptor antagonist, is considered an interesting and effective animal model in the study of seizure mechanisms, and it is usable to predict the effects of anticonvulsive drugs (Löscher, 2002) . More importantly, several studies have shown that PTZ administration produces damage in macromolecules from neurons, such as DNA, proteins and lipids (Akbas et al., 2005; Guzman et al., 2005; Ilhan et al., 2004 Ilhan et al., , 2005 De Oliveira et al., 2008) .
Each year, 125,000 new cases of epilepsy are diagnosed but only 70% of patients are effectively treated with currently available antiepileptic drugs (Kwan and Brodie, 2007) . For a substantial number of patients, pharmacotherapies used today are not effective to control symptoms. In view of that, there is a substantial need for more effective drugs (Kwan and Brodie, 2007) . Neuropeptides are potent modulators of neuronal excitability, which generally, under physiological conditions, are "silent" and exert little effect on normal neurotransmission. However, under conditions of excessively high neuronal firing (i.e., epileptic seizures), neuropeptides are released and exert modulatory effects on neurotransmission (Hokfelt et al., 2000) .
Neuropeptide S (NPS) is a 20 amino-acid peptide identified in the brain and peripheral tissues of distinct species of vertebrates (Xu et al., 2004) . NPS is the endogenous ligand of a G protein-coupled receptor named NPSR receptor (Xu et al., 2004) . This novel peptidergic system regulates several central biological functions, which includes anxiety (Jüngling et al., 2008; Leonard et al., 2008; Rizzi et al., 2008; Vitale et al., 2008) , arousal Xu et al., 2004) , food intake (Beck et al., 2005; Fedeli et al., 2009; Smith et al., 2006) , locomotion (Pacheco et al., 2011; Castro et al., 2009a Castro et al., , 2009b Leonard et al., 2008; Mochizuki et al., 2010; Okamura et al., 2008; Rizzi et al., 2008; Roth et al., 2006; Smith et al., 2006; Xu et al., 2004) , nociception Peng et al., 2010) , memory processing Okamura et al., 2011) , and motivational behaviors Cao et al., 2011) .
It should be noted that the pattern of effects of NPS on sleep and emotional behavior is quite unique. In fact, identical dose ranges of NPS evoke, at the same range, anxiolysis and wakefulness, a property that is found neither in the available anxiolytic drugs, such as benzodiazepines, nor in psychostimulant drugs, such as amphetamine and cocaine. These latter drugs potently induce arousal, though simultaneously appear to be anxiogenic (for a review see: Reinscheid et al., 2005) . Thus, considering this quite paradoxical anxiolytic and psychostimulant profile of action of NPS in rodents, and the lack of information regarding the effects of NPS on seizures, this study investigates the behavioral effects of NPS in mice submitted to the animal model of seizures induced by the repeated administration of PTZ.
Studies on rodent animal models of seizure have shown an increase in the generation of reactive oxygen and nitrogen species, which leads to the oxidation of cellular macromolecules in brain areas (Bellissimo et al., 2001; Erakovic et al., 2003; Freitas, 2009; Freitas et al., 2005) . Additionally, the involvement of free radicals in seizures is also supported by reports showing antioxidants exogenously administered to protect the brain against seizure-induced neuronal damage Santos et al., 2008; Tomé et al., 2010; Xavier et al., 2007) .
Data from literature have suggested that NPS may have neuroprotective effects. Okamura et al. (2010) showed that NPS may have protective effects against the neurotoxic and behavioral changes produced by NMDA receptor antagonists. Castro et al. (2009a) showed that acute administration of NPS attenuates oxidative damage to lipids and proteins produced by the i.c.v. procedure per se in mice, and this effect of NPS against oxidative damage to lipids and proteins was prevented by the administration of lithium and valproate (Castro et al., 2009b) . Nevertheless, no information is available about the actions of NPS under chemical stimulus-induced macromolecule oxidation. Thus, based on the context cited above, this study was aimed to investigate the effects of NPS on the oxidative stress damage induced by PTZ to macromolecules, such as proteins, lipids and DNA in hippocampus and cerebral cortex.
Material and methods

Materials
Pentylenetetrazole (PTZ) was purchased from Sigma-Aldrich (code No. P6500). Human NPS was synthesized by Dr R. Guerrini, Department of Pharmaceutical Science and Biotechnology Center, University of Ferrara, according to published methods (Roth et al., 2006) . NPS and PTZ were dissolved in saline solution (NaCl 0.9%, w/v). All other chemicals were of analytical reagent grade and purchased from local suppliers.
Animals
Male CF-1 mice (2-3 months, 45-55 g) were obtained from our breeding colony (UNESC). The animals were housed six per cage with food and water freely available and were maintained on a 12-h light/dark cycle (lights on at 7:00 am). Each animal was used only once. All experimental procedures involving animals were performed in accordance with the Brazilian Law for the care and use of laboratory animals. This study was approved by the local ethics committee (Comitê de Ética em Pesquisa da Universidade do Extremo Sul Catarinense; Protocol number: 332/2008).
Treatments
The PTZ-induced seizures treatment was based on the study of De Oliveira et al. (2008) . Animals were injected subcutaneously with PTZ 60 mg/kg or saline solution (NaCl 0.9%) once every three days, comprising a total of six injections (last injection 16 days after the first injection). Injections were given between 7 and 11 a.m. In the last treatment day, 5 min before the injection of PTZ or saline, animals received 2 μL via i.c.v. saline or NPS at distinct doses (1, 0.1 and 0.01 nmol). The i.c.v. injection was based on "free hand" technique as described by Laursen and Belknap (1986) , and previously adopted by our research group (Castro et al., 2009a (Castro et al., , 2009b . Briefly, under light ether anesthesia (just enough to promote the losing of the righting reflex), a 27-gauge needle attached to a 10 μL Hamilton syringe was inserted perpendicularly 3 mm deep through the skull, into the left ventricle, 2 mm laterally from the midline on the line drawn through the anterior base of the ears.
In summary, as illustrated in Fig. 1 , eight treatment groups were employed in this study, as follows: (control) just after behavioral assessment, animals were euthanized by decapitation, and cerebral cortex and hippocampus were dissected, to proceed with biochemical analysis.
Behavioral analysis
After each PTZ or saline injection, animals were placed in acrylic observation chambers for 30 min. During the behavioral assessment, the following parameters were registered: latency to the first seizure severity score III, duration of the first seizure severity score III (both in seconds), and the number of seizures.
Additionally, convulsive behavior was rated according to the following scale (adapted from Da Silva et al., 1998) : 0 = no convulsive behavior; I = jerks of short duration; II = clonic forelimb convulsions lasting less than 3 s; III = clonic forelimb convulsions lasting more than 3 s; IV = generalized convulsions with tonic extension episodes and full status epilepticus; V = death. In the present study, we used in behavioral and biochemical assays only those animals which presented seizures at a severity score rate ≥ III.
Lipid peroxidation
Lipid peroxidation was measured by formation of thiobarbituric acid (TBA) reactive substances (TBARS) according to published methods (Esterbauer and Cheeseman, 1990) and previously adopted by our research group (Castro et al., 2009a (Castro et al., , 2009b . Data were expressed as nmol of TBARS equivalents per mg of protein.
Protein carbonyl formation
Protein carbonyl content was measured in the brain homogenates according to published methods (Levine et al., 1994) and previously adopted by our research group (Castro et al., 2009a (Castro et al., , 2009b . Protein carbonyl levels were expressed as nmol of carbonyl per mg of protein.
Comet assay
Alkaline comet assay was carried out as described by Tice et al. (2000) and previously adopted by our research group (Zugno et al., 2008) . The slides were stained with silver, as described by Nadin et al. (2001) , and analyzed under a microscope. Images of 100 randomly selected cells from each animal (50 cells without choosing intentionally from each of two replicate slides) were analyzed. DNA migration was determined visually by the categorization of comets into different 'classes' of migration (Collins et al., 1997) . All analyses were performed by a blinded investigator.
Statistical analyses
Behavioral data are expressed as mean± SD of 15-20 animals/group and biochemical data are presented as mean± SEM of 5-8 animals/ group. The comet assay was performed employing brain structures of 4-5 animals/group, and these data are presented as mean ± SD. The normality of variables was evaluated by the Kolmogorov-Smirnov test. Duration and latency of convulsions between groups were analyzed by one-way ANOVA followed by Tukey's test, while the frequency of PTZ-induced convulsions, expressed as the percentage (and the raw number) of animals exhibiting score III convulsions were analyzed by Fisher's Exact test. Differences among experimental groups at biochemical analysis were determined by one-way ANOVA followed by Duncan's test (oxidative damage to proteins and lipids) and Tukey's test (comet assay). All statistical analyses were performed using the statistical package SPSS 12.0 for Windows (SPSS, Inc., Chicago, IL, USA). In all experiments, P-values lower than 0.05 were considered to be statistically significant. Table 1 shows the percentage of animals repeatedly treated with PTZ, which displayed seizure severity score III (i.e. clonic forelimb convulsions lasting more than 3 s). Clonic seizure activity was defined as the seizure behaviors rated as scores III and IV. In our experimental conditions, mice of the group PTZ showed seizure rated score III (65%), and a non-significant number of mice showed convulsive behavior scored IV or V. The acute treatment with NPS at 0.01, 0.1 and 1 nmol, 30 min before the last injection of PTZ, neither modified the number of animals which displayed seizure severity score III (Table 1 ; P > 0.05 for all comparisons; Fisher's Exact test) nor the latency for the first seizure severity score III (Table 1 ; P > 0.05 for all comparisons; ANOVA, Tukey's test). However, NPS at 1 nmol significantly increased the duration of seizures when compared to control (Table 1 ; F (3.67) = 3.16; P = 0.03; ANOVA, Tukey's test).
Results
The content of protein carbonyl formation and TBARS equivalents in the hippocampus and cerebral cortex of mice treated with PTZ and NPS, at increasing doses, is shown in Figs. 2 and 3 , respectively. The levels of protein carbonyl formation in the hippocampus and cerebral cortex in mice treated with saline (i.p.) and NPS (i.c.v.) did not differ from the control group ( Fig. 2A and B, respectively) . However, the i.c.v. administration of NPS (in saline i.p. pretreated mice) reduced significantly TBARS equivalents in the hippocampus ( Fig. 3A ; F (7.47) = 22.71; P b 0.0001, ANOVA, Duncan's test), but not in the cerebral cortex (Fig. 3B) .
It is important to note that the repeated administration of PTZ caused a substantial increase in protein carbonyl formation in the hippocampus and cerebral cortex of mice ( Fig. 2A ; F (7.21) = 2.51, P = 0.048, and Fig. 2B ; F (7.20) = 9.07, P b 0.0001, respectively, ANOVA, Duncan's test) and TBARS equivalent levels ( Fig. 3A ; F (7.47) = 22.71, P b 0.0001, and Fig. 3B ; F (7.47) = 12.19, P b 0.0001, ANOVA, Duncan's test) in the same brain structures when compared to saline-treated mice. Regarding the biochemical effects of NPS on PTZ-treated mice, in the hippocampus, the i.c.v. administration of NPS 0.1 nmol before the last injection of PTZ caused a statistically significant decrease in protein carbonyl formation ( Fig. 2A ; F (7.21) = 2.51; P = 0.048, ANOVA, Duncan's test). Also in the hippocampus, the increase in TBARS equivalent formation induced by PTZ was reduced by the treatment with NPS at all doses tested ( Fig. 3A ; F (7.47) = 22.71; P b 0.0001, ANOVA, Duncan's test). A similar effect was observed in the cerebral cortex, in which oxidative damage to proteins and lipids evoked by PTZ was significantly attenuated by NPS treatment ( Fig. 2B ; F (7.20) = 9.07, P b 0.0001 for carbonylated proteins; Fig. 3B ; F (7.47) = 12.19; P b 0.0001 for lipid peroxidation; ANOVA, Duncan's test). Table 2 shows the effects of PTZ-induced seizures in mice treated with NPS on DNA damage in the hippocampus and cerebral cortex. In the cerebral cortex, the treatment with NPS before the last administration of PTZ did not affect the damage index and the frequency of damage on DNA, when compared to the PTZ group (Table 2; P > 0.05). However, statistically significant differences were observed in DNA damage (i.e., damage index and damage frequency to DNA) only in the hippocampus of PTZ-treated mice i.c.v. injected with NPS at the higher dose when compared to PTZ plus saline ( 
Discussion
The data herein presented could be summarized as follows: (1) a high dose of NPS slightly increased the duration of class III seizures induced by repeated administration of PTZ; (2) a range of doses of NPS attenuated PTZ-induced oxidative damage to proteins and lipids in the hippocampus and cerebral cortex; (3) NPS at the high dose increased PTZ-induced DNA damage in the hippocampus (but not in the cerebral cortex). A paradoxical effect for NPS was detected when analyzing the presented data. In fact, NPS facilitated the effects of PTZ by increasing the duration of seizures and DNA damage in the hippocampus, and, in contrast, NPS attenuated the effects of PTZ-induced oxidative damage to proteins and lipids in the hippocampus and cerebral cortex.
Studies have suggested that the GABAergic (Rocha et al., 1996) , but also there is an involvement of glutamatergic (Jensen et al., 1997) , and adenosinergic systems (Pagonopoulou and Angelatou, 1998) are involved in PTZ-induced seizures. Additionally, alterations in NMDA, kainite, A1 receptors and benzodiazepine binding site densities were detected in the brain of mice repeatedly treated with PTZ (Cremer et al., 2009) .
Literature findings suggest a role for adenosinergic system in mediating the stimulatory effects of NPS in mice (Pacheco et al., 2011; Boeck et al., 2010) . Boeck et al. (2010) have showed that the blockade of A 2A receptors prevents the hyperlocomotion evoked by NPS. Considering that the genetic and pharmacological blockade of A 2A receptors induces protective effects against PTZ-induced seizures (El Yacoubi et al., 2008 , 2009 , it could be hypothesized that adenosine is produced by NPS, and acting on A 2A (a Gs/olf protein coupled receptor), adenosine could mediate NPS-induced neuronal excitability. Additionally, the expression of mRNA NPS-NPSR receptor system can be modulated by acute and repeated treatment with caffeine (Lage et al., 2006) . Further studies aiming to investigate the participation of A 2A receptors in mediating the facilitatory action of NPS in seizures induced by PTZ in mice are necessary.
Regarding the role of A 1 receptors in the mediation of NPS-induced stimulant effects, literature data have showed that the blockade of A 1 receptors further increases the psychostimulant effect of NPS (Boeck Cremer et al. (2009) have showed that A 1 binding sites were down-regulated in the amygdala and hippocampal CA1 region in PTZ-induced seizures in mice. In contrast, Tchekalarova et al. (2005) showed that PTZ kindling induced upregulation of A 1 receptor binding in cortex, hippocampus, amygdala and geniculate nuclei. These contrasting differences could be due to the protocol of PTZ-induced kindling used or the specific brain area analyzed in these studies. Based on the available literature findings, it could be hypothesized that PTZ-induced seizure could decrease A 1 receptor densities in the brain, thus reducing the inhibitory actions of adenosine on A 1 receptors (a Gi/o protein coupled receptor) in NPS-induced stimulatory effects, thus evoking neuronal hyperexcitability. The effects described above on A 1 receptors could explain -together with the activation of A 2A receptor -the NPS-induced facilitatory effects on neuronal excitability evoked by PTZ. On the other hand, considering that PTZ-induced kindling increased adenosine A 1 receptor binding sites (Tchekalarova et al., 2005) , the up-regulation of A 1 receptors might represent a mechanism for coping with PTZ-induced damage to macromolecules, and it could explain the protective effects of NPS against protein carbonyl formation and lipid peroxidation evoked by PTZ. Indeed, the effects of NPS (at high dose) in slightly increasing the duration of PTZ-induced seizures could be due to a fine modulation of adenosine by acting on stimulatory A 2A and inhibitory A 1 receptors.
It is worth mentioning that repeated seizures cause progressive molecular and cellular changes in the brain, including activation of glutamate receptors, and second messengers, besides the formation of transcription factors (Li et al., 2000; Sejima et al., 1997) . In this regard, we should consider the fact that the effects of NPS (at the highest dose) on duration of seizures could be mediated by other neurotransmitters besides adenosine, including glutamate, acetylcholine, 5-HT, dopamine and/or corticotrophin-release factor. In fact, these neurotransmitters have been reported to be involved in some effects induced by NPS in the rodent brain (Jüngling et al., 2008; Mochizuki et al., 2010; Okamura et al., 2010; Pañeda et al., 2009; Raiteri et al., 2009; Si et al., 2010; Xu et al., 2007 ). An up-regulation of NMDA receptors in the hippocampus and cerebral cortex in PTZ-induced seizures has been previously reported (Cremer et al., 2009; Jensen et al., 1997) . Considering the NPS-NPSR receptor system, it should be mentioned that NPS precursor is expressed in only a few brainstem nuclei where it is co-expressed with various excitatory neurotransmitters, including glutamate (Xu et al., 2007) . Additionally, Pape et al. (2010) showed that NPS increases release of glutamate in synaptic circuits within the amygdala. No information is available in the literature about the effects of NPS on glutamate release in the hippocampus and cerebral cortex, but considering the alteration in glutamate receptor densities evoked by PTZ-induced kindling (Cremer et al., 2009; Jensen et al., 1997) , we could hypothesized that NPS at high dose could facilitate neuronal excitability and damage to DNA due to the release of glutamate in the brain structures triggered by PTZ. Studies aimed to investigate this hypothesis are required.
It should be noted that the repeated administration of PTZ, under our experimental conditions, induced damage to lipids and proteins in the mouse hippocampus and cerebral cortex. These data are in line with the literature, which reported an increase of oxidative stress to macromolecules in the brain of mice (Patsoukis et al., 2005; Uma Devi et al., 2006) and rats (Arora et al., 2010) repeatedly treated with PTZ. Previously, it has been reported that NPS attenuates oxidative damage to lipids and proteins induced by the i.c.v. injection procedure (Castro et al., 2009a (Castro et al., , 2009b . Interestingly, the present study showed for the first time the protective effects of NPS in PTZ-induced damage to macromolecules, even at the NPS dose that increased duration of seizures in PTZ-treated mice. The effects of NPS against PTZ-induced damage to lipids and proteins could be explained by adaptative alterations in antioxidant enzyme activity (catalase and superoxide dismutase) (Castro et al., 2009a) , which could evoke a mechanism aimed to cope with the neuronal damage induced by hyperexcitability. Another explanation to this protective effect of NPS against damage to lipids and proteins might involve ion flux (Castro et al., 2009b) . In fact, the pretreatment with lithium and valproate, which affect directly or indirectly Ca 2+ and Na + intracellular concentrations, prevents the attenuation of oxidative damage to lipids and proteins evoked by NPS (Castro et al., 2009b) . As a final point, in adenosine and glutamate neurotransmitters could also be involved in mediating the protective effects of NPS on damage to lipids and proteins induced by PTZ. The comet assay in brain tissue is useful in the investigation of the genotoxic/antigenotoxic effects of drugs acting on the brain (Zugno et al., 2008) . The comet assay detects a broad spectrum of DNA lesions, including double and single strand breaks (Tice et al., 2000) . Our findings showed that NPS did not modify damage to DNA induced by the repeated administration of PTZ, but NPS, only at the dose which facilitated PTZ-induced seizures, increased frequency of damage and damage index on DNA in the hippocampus (but not cerebral cortex) of PTZ-treated mice. The significant increase in DNA damage evoked by NPS 1 nmol could be due to the slight facilitatory effects of NPS in evoking PTZ-induced seizures. It should be mentioned that, at this point, we are unaware whether the increased DNA fragmentation observed in the hippocampus by comet assay will persist, in which case the apoptosis signaling pathway would consequently be activated, or the DNA damage be repaired. Additional studies aimed to answer this question are necessary to evaluate the putative detrimental effects of NPS on neuronal survival.
Finally, we cannot rule out the involvement of other excitatory neurotransmitters, such as dopamine and corticotrophin-release factor, in the facilitatory effects of NPS in the neuronal excitability evoked by PTZ. In fact, the above mentioned neurotransmitters have been reported to mediate the biological actions exerted by the i.c.v. administration of NPS in the rodent brain (Mochizuki et al., 2010; Pañeda et al., 2009; Si et al., 2010) .
Conclusion
In conclusion, the present findings demonstrated that, from the behavioral standpoint, NPS administration, only at the high dose, slightly facilitated neuronal excitability, which was observed by an increase in duration of PTZ-induced seizure. Biochemical analysis revealed, for the first time, that NPS attenuated oxidative damage evoked by PTZ to macromolecules, such as lipids and proteins, in the hippocampus and cerebral cortex. Concerning DNA, NPS was not effective in reducing DNA fragmentation induced by PTZ; oppositely, NPS (at the high dose) increased DNA damage only in the mouse hippocampus, thus suggesting that DNA damage is correlated to proconvulsive effects of NPS. Altogether, NPS displays little proconvulsive effects and, at the same doses, prevents oxidative damage to lipids and proteins evoked by a 196.3 ± 42.6 ⁎ 56.5 ± 9.8 ⁎ 208.2 ± 34.6 60.4 ± 9.4 DI (damage index) can range from 0 (completely undamaged, 100 cells×0) to 400 (with maximum damage, 100×4). DF (damage frequency) was calculated based on the number of cells with tail versus those with no tail. Data are expressed as mean±S.D. ⁎ P b 0.05 vs. PTZ group (n = 4-5), according to one-way ANOVA followed by the post-hoc Tukey's test. chemical stimulus. Additional studies focused on investigating the blockade of NPSR receptor signaling in animal models of seizure are mandatory for understanding the participation of NPS-NPSR receptor system in seizures.
